Identifying dermatologic conditions in pediatric patients with COVID-19
A recent article suggests physicians should be on the lookout for various dermatologic manifestations in pediatric patients suspected of having COVID-19.
Related Articles
ICYMI: US FDA Recently Approves Stelara Biosimilar Ustekinumab-aekn for Psoriasis, Psoriatic Arthritis
Last week, the US Food and Drug Administration approved biosimilar ustekinumab-aekn (Selarsdi; Alvotech and Teva) for psoriasis and PsA.
The Weekly Roundup: April 15-19
ICYMI, this week we had news about partnering with Spherix Global Insights, a look back at the rosacea pipeline, what dermatology clinicians need to know…
Tracee Blackburn, PA-C: Gut Health for Healthy Skin
Blackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.
Half of Patients With Psoriasis Receiving Placebo In Clinical Trials Report Adverse Events
A recent review and meta-analysis says this statistic may be due in part to nocebo effects.
European Union Approves Bimekizumab to Treat HS
The European approval was based on data from the Phase III BE HEARD I and BE HEARD II trials.
QUIZ RECAP: Test Your Knowledge of Rosacea Complications and Comorbidities
Earlier this week, we shared our second Rosacea Awareness Month quiz. Review the answers and your responses below.
Mobile Health Technologies In Studies of Actinic Keratosis Do Not Compromise Patient Safety, Research Article Says
Researchers examined local skin reactions of a topical gel inhibiting cytosolic phospholipase A2 both in-clinic and remotely.
Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients
Scurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting.
Exploring Long-Term Data and Combination Therapies
Brian Kim, MD, explores long-term ruxolitinib data and combination therapies in the treatment of pediatric atopic dermatitis.
Introducing Omar Noor, MD, FAAD: Dermatology Times’ Newest Editorial Advisory Board Member
Noor, the co-owner of Rao Dermatology, shares about his interests in dermatology and what he most looks forward to as a member of our board.